Author
Listed:
- Francieli Rohden
(University of Pittsburgh
Universidade Federal do Rio Grande do Sul)
- Pamela C. L. Ferreira
(University of Pittsburgh)
- Bruna Bellaver
(University of Pittsburgh)
- João Pedro Ferrari-Souza
(University of Pittsburgh
Universidade Federal do Rio Grande do Sul)
- Cristiano S. Aguzzoli
(University of Pittsburgh
PUCRS
University of California)
- Carolina Soares
(University of Pittsburgh
Universidade Federal do Rio Grande do Sul)
- Sarah Abbas
(University of Pittsburgh)
- Hussein Zalzale
(University of Pittsburgh)
- Guilherme Povala
(University of Pittsburgh)
- Firoza Z. Lussier
(University of Pittsburgh)
- Douglas T. Leffa
(University of Pittsburgh)
- Guilherme Bauer-Negrini
(University of Pittsburgh)
- Nesrine Rahmouni
(Le Centre intégré universitaire de santé et de services sociaux (CIUSSS) de l’Ouest-de-l’Île-de-Montréal
McGill University)
- Cécile Tissot
(University of Pittsburgh
Le Centre intégré universitaire de santé et de services sociaux (CIUSSS) de l’Ouest-de-l’Île-de-Montréal
McGill University)
- Joseph Therriault
(Le Centre intégré universitaire de santé et de services sociaux (CIUSSS) de l’Ouest-de-l’Île-de-Montréal
McGill University)
- Stijn Servaes
(Le Centre intégré universitaire de santé et de services sociaux (CIUSSS) de l’Ouest-de-l’Île-de-Montréal
McGill University)
- Jenna Stevenson
(Le Centre intégré universitaire de santé et de services sociaux (CIUSSS) de l’Ouest-de-l’Île-de-Montréal
McGill University)
- Andrea L. Benedet
(The Sahlgrenska Academy at the University of Gothenburg
Sahlgrenska University Hospital)
- Nicholas J. Ashton
(The Sahlgrenska Academy at the University of Gothenburg
Sahlgrenska University Hospital
University of Gothenburg
King’s College London)
- Thomas K. Karikari
(University of Pittsburgh
The Sahlgrenska Academy at the University of Gothenburg
Sahlgrenska University Hospital)
- Dana L. Tudorascu
(University of Pittsburgh
University of Pittsburgh)
- Henrik Zetterberg
(The Sahlgrenska Academy at the University of Gothenburg
Sahlgrenska University Hospital
UCL Queen Square Institute of Neurology
UK Dementia Research Institute at UCL)
- Kaj Blennow
(The Sahlgrenska Academy at the University of Gothenburg
Sahlgrenska University Hospital)
- Eduardo R. Zimmer
(Universidade Federal do Rio Grande do Sul
PUCRS
Universidade Federal do Rio Grande do Sul
Universidade Federal do Rio Grande do Sul)
- Diogo Souza
(Universidade Federal do Rio Grande do Sul)
- Pedro Rosa-Neto
(Le Centre intégré universitaire de santé et de services sociaux (CIUSSS) de l’Ouest-de-l’Île-de-Montréal
McGill University)
- Tharick A. Pascoal
(University of Pittsburgh
University of Pittsburgh)
Abstract
Previous studies suggest glial and neuronal changes may trigger synaptic dysfunction in Alzheimer’s disease (AD), but the link between their markers and synaptic abnormalities in the living brain remains unclear. We investigated the association between glial reactivity and synaptic dysfunction biomarkers in cerebrospinal fluid (CSF) from 478 individuals in cognitively unimpaired (CU) and cognitively impaired (CI) individuals. We measured amyloid-β (Aβ), phosphorylated tau (pTau181), astrocyte reactivity (GFAP), microglial activation (sTREM2), and synaptic markers (GAP43, neurogranin). CSF GFAP levels were associated with presynaptic and postsynaptic dysfunction, independent of cognitive status or Aβ presence. CSF sTREM2 levels were related to presynaptic markers in cognitively unimpaired and impaired Aβ+ individuals, and to postsynaptic markers in cognitively impaired Aβ+ individuals. Notably, CSF pTau mediated the relationships between GFAP or sTREM2 and synaptic dysfunction. Our findings, validated in two independent cohorts (TRIAD and ADNI), reveal a distinct pattern of glial contribution to synaptic degeneration.
Suggested Citation
Francieli Rohden & Pamela C. L. Ferreira & Bruna Bellaver & João Pedro Ferrari-Souza & Cristiano S. Aguzzoli & Carolina Soares & Sarah Abbas & Hussein Zalzale & Guilherme Povala & Firoza Z. Lussier & , 2025.
"Glial reactivity correlates with synaptic dysfunction across aging and Alzheimer’s disease,"
Nature Communications, Nature, vol. 16(1), pages 1-10, December.
Handle:
RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-60806-1
DOI: 10.1038/s41467-025-60806-1
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-60806-1. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.